To help Biological E make 1 billion COVID doses
The U.S. International Development Finance Corporation (DFC) has said it will assist vaccine maker Biological E scale up to produce at least one billion doses of COVID-19 vaccines by 2022, including Johnson & Johnson vaccines.
“It is hard to conceive of an investment with a greater developmental impact than using our financial tools to increase the capacity of vaccine manufacturing to help developing countries in Asia and around the world respond to COVID-19 and other diseases,” DFC COO David Marchick said in a statement. It seeks to invest $5-500 million on each eligible project, pertaining to COVID vaccines, through a range of financial tools, which includes equity and debt financing, political risk insurance, and technical development.
Australia, the United States, India and Japan have agreed to manufacture at least one billion more COVID-19 vaccine doses by the end of next year for distribution across Asia.
Welcome To IANS Live - NATION - US bank to enhance Biological E s capacity for Covid vax ianslive.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ianslive.in Daily Mail and Mail on Sunday newspapers.
Washington [US] March 13 (ANI): The US International Development Finance Corporation (DFC) has announced it will support Indian manufacturer Biological E's efforts to produce at least 1 billion doses of COVID-19 vaccines by the end of 2022 with stringent regulatory authorization (SRA) and/or WHO Emergency Use listing including Johnson & Johnson vaccines.
March 13, 2021
Biological E Ltd s vaccine plant at Shamirpet×
Announcement in line with Quad leaders decision to work together on vaccine production, distribution In a major boost to India’s vaccine production drive, the US International Development Finance Corporation (DFC), the country’s development bank, has announced that it will finance Indian manufacturer Biological E Ltd’s effort to produce at least 1 billion doses of Covid-19 vaccines by the end of 2022 which will also include Johnson & Johnson vaccines.
This is in line with the Quad leaders’ decision on Friday to work together to develop and distribute Covid-19 vaccines to wipe off the pandemic from the world. The Quad Summit was attended by Prime Minister Narendra Modi, US President Joe Biden, Australian PM Scott Morrison and Japanese PM Yoshihide Suga.